Wayne Shepherd, Joins Grenova as Global Vice President of Sales

New Global VP of Sales to Drive Expansion of Green Technology for Lab Consumables

Grenova, the innovative manufacturer of green technology for lab consumables, announced today that Wayne Shepherd has been appointed Global Vice President of Sales. Shepherd joins Grenova during a period of explosive growth as the organization expands operations to meet a dramatic increase in demand for automated, high-throughput pipette tip and microwell plate washers. As a leader in the life sciences industry with 20 years of experience, he will drive Grenova’s growth as it provides patented technology to labs around the world.

“It’s an honor to join Grenova as we push the life sciences industry into the future by finding innovative ways to reuse plastic consumables to protect the environment while cutting costs and creating supply chain resilience,” said Shepherd. “Grenova is leading this charge with the only green technology capable of washing and reusing plastic consumables to make labs smarter, greener, and cleaner.”

Prior to joining Grenova, Shepherd served as Vice President of Health Systems and Vice President of Sales – East at AccuVein, Global Vice President of Sales and Marketing at BG Medicine, Regional Sales Director at Abbott, Diabetes Management Consultant at Medtronic Diabetes, Area Manager and Regional Trainer at Novartis, and founder and president of Commonwealth Consulting. He has extensive experience and a consistent record of outstanding performance in corporate management, business development, and executive leadership. Shepherd has successfully built and defended market positions in the capital, disposable, and medical device spaces within both the acute and non-acute markets.

“Team Grenova is proud to call Wayne Shepherd a Grenovian,” said Ali Safavi, founder and CEO of Grenova. “Wayne defines the values of Grenova and is the type of leader that is driven by an unwavering sense of purpose. Best of all, he’s always ready to collaborate with others in the lab industry and is committed to reimagining what is possible when labs wash and reuse their plastic consumables.”

Today, Grenova’s tip washers are implemented in the largest domestic and international labs around the world and are relied upon by NIH, NCI, and the CDC. Partner labs report a dramatic reduction in plastic pipette tip consumption by 90 percent, resulting in significant cost savings while dramatically cutting plastic waste.

SourceGrenova

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.